跳转至内容
Merck
CN
  • Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.

Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.

International journal of nanomedicine (2017-06-16)
Mohamed Wehbe, Malathi Anantha, Minghan Shi, Ada Wai-Yin Leung, Wieslawa H Dragowska, Léon Sanche, Marcel B Bally
摘要

Copper diethyldithiocarbamate (Cu(DDC)